课题基金 / 基金详情

Optimizing the Use of Adjuvant Chemotherapy for Colon Cancer: A Population-Based Study of Practice and Outcomes

Optimizing the Use of Adjuvant Chemotherapy for Colon Cancer: A Population-Based Study of Practice and Outcomes
优化结肠癌辅助化疗的使用：基于人群的实践和结果研究
批准号：
321295
负责人：
Booth Christopher M
金额：
$15.89万
依托单位：
Queen's University (Kingston, Ontario)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2015
资助国家：
加拿大
项目状态：
已结题
起止时间：
2015-03-01 至 2018-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=321295&lang=en
关键词：
Chemotherapy Colon Cancer Health Services Research Outcomes Patterns Of Care Quality Of Care Surgery

项目摘要

项目成果

Booth Christopher M的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Since the 1990s, treatment guidelines recommend that patients with colon cancer receive chemotherapy after surgery. There are now 3 different chemotherapy treatment options for these patients. The purpose of this study is to evaluate whether patients are
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Canada Research Chair Tier 2
CRC Tier 2
Adoption of Adjuvant Chemotherapy for Non-Small Cell Lung Cancer in Ontario: A Population-Based Outcomes Study
Adoption of Adjuvant Chemotherapy for Non-Small Cell Lung Cancer in Ontario: A Population-Based Outcomes Study
海外基金